Recent 8-K filings for PLX

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 13, 2026 10:57 UTC earnings item 2.02item 9.01

  Protalix BioTherapeutics Reports First Quarter 2026 Financial Results and Reaffirms Guidance

source · PLX on sec.gov